106 related articles for article (PubMed ID: 3334988)
1. Nonrandom chromosome alterations in human malignant mesothelioma.
Popescu NC; Chahinian AP; DiPaolo JA
Cancer Res; 1988 Jan; 48(1):142-7. PubMed ID: 3334988
[TBL] [Abstract][Full Text] [Related]
2. Recurrent deletions of specific chromosomal sites in 1p, 3p, 6q, and 9p in human malignant mesothelioma.
Taguchi T; Jhanwar SC; Siegfried JM; Keller SM; Testa JR
Cancer Res; 1993 Sep; 53(18):4349-55. PubMed ID: 8364929
[TBL] [Abstract][Full Text] [Related]
3. High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints.
Wistuba II; Behrens C; Virmani AK; Mele G; Milchgrub S; Girard L; Fondon JW; Garner HR; McKay B; Latif F; Lerman MI; Lam S; Gazdar AF; Minna JD
Cancer Res; 2000 Apr; 60(7):1949-60. PubMed ID: 10766185
[TBL] [Abstract][Full Text] [Related]
4. Clonal chromosome abnormalities in tumor cells from patients with sporadic renal cell carcinomas.
Kovacs G; Frisch S
Cancer Res; 1989 Feb; 49(3):651-9. PubMed ID: 2910484
[TBL] [Abstract][Full Text] [Related]
5. Deletions in chromosome arms 3p and 11q are new prognostic markers in localized and 4s neuroblastoma.
Spitz R; Hero B; Ernestus K; Berthold F
Clin Cancer Res; 2003 Jan; 9(1):52-8. PubMed ID: 12538451
[TBL] [Abstract][Full Text] [Related]
6. Nonrandom chromosome changes in malignant melanoma.
Becher R; Gibas Z; Karakousis C; Sandberg AA
Cancer Res; 1983 Oct; 43(10):5010-6. PubMed ID: 6883347
[TBL] [Abstract][Full Text] [Related]
7. Recurrent cytogenetic aberrations in human ovarian carcinomas.
Kiechle-Schwarz M; Bauknecht T; Schmidt J; Walz L; Pfleiderer A
Cancer Detect Prev; 1995; 19(3):234-43. PubMed ID: 7750111
[TBL] [Abstract][Full Text] [Related]
8. Chromosome 12 breakpoints are cytogenetically different in benign and malignant lipogenic tumors: localization of breakpoints in lipoma to 12q15 and in myxoid liposarcoma to 12q13.3.
Mrózek K; Karakousis CP; Bloomfield CD
Cancer Res; 1993 Apr; 53(7):1670-5. PubMed ID: 8453640
[TBL] [Abstract][Full Text] [Related]
9. Chromosomal deletion in patients with malignant pleural mesothelioma.
Neragi-Miandoab S; Sugarbaker DJ
Interact Cardiovasc Thorac Surg; 2009 Jul; 9(1):42-4. PubMed ID: 19346221
[TBL] [Abstract][Full Text] [Related]
10. Recurrent chromosome alterations in non-small cell lung cancer.
Matturri L; Lavezzi AM
Eur J Histochem; 1994; 38(1):53-8. PubMed ID: 7517731
[TBL] [Abstract][Full Text] [Related]
11. Codeletion of p15 and p16 in primary malignant mesothelioma.
Xio S; Li D; Vijg J; Sugarbaker DJ; Corson JM; Fletcher JA
Oncogene; 1995 Aug; 11(3):511-5. PubMed ID: 7630635
[TBL] [Abstract][Full Text] [Related]
12. Recurring loss involving chromosomes 1, 3, and 22 in malignant mesothelioma: possible sites of tumor suppressor genes.
Flejter WL; Li FP; Antman KH; Testa JR
Genes Chromosomes Cancer; 1989 Nov; 1(2):148-54. PubMed ID: 2487155
[TBL] [Abstract][Full Text] [Related]
13. Multiple recurrent chromosomal breakpoints in mantle cell lymphoma revealed by a combination of molecular cytogenetic techniques.
Salaverria I; Espinet B; Carrió A; Costa D; Astier L; Slotta-Huspenina J; Quintanilla-Martinez L; Fend F; Solé F; Colomer D; Serrano S; Miró R; Beà S; Campo E
Genes Chromosomes Cancer; 2008 Dec; 47(12):1086-97. PubMed ID: 18709664
[TBL] [Abstract][Full Text] [Related]
14. Nonrandom chromosomal changes in transitional cell carcinoma of the bladder.
Gibas Z; Prout GR; Connolly JG; Pontes JE; Sandberg AA
Cancer Res; 1984 Mar; 44(3):1257-64. PubMed ID: 6692407
[TBL] [Abstract][Full Text] [Related]
15. 1p and 3p deletions in meningiomas without detectable aberrations of chromosome 22 identified by comparative genomic hybridization.
Carlson KM; Bruder C; Nordenskjöld M; Dumanski JP
Genes Chromosomes Cancer; 1997 Dec; 20(4):419-24. PubMed ID: 9408760
[TBL] [Abstract][Full Text] [Related]
16. Karyotypic comparisons of multiple tumorous and macroscopically normal surrounding tissue samples from patients with breast cancer.
Teixeira MR; Pandis N; Bardi G; Andersen JA; Heim S
Cancer Res; 1996 Feb; 56(4):855-9. PubMed ID: 8631024
[TBL] [Abstract][Full Text] [Related]
17. Chromosome abnormalities in leukemia and lymphoma.
Rowley JD
Ann Clin Lab Sci; 1983; 13(2):87-94. PubMed ID: 6602585
[TBL] [Abstract][Full Text] [Related]
18. Loss of heterozygosity analysis defines a critical region in chromosome 1p22 commonly deleted in human malignant mesothelioma.
Lee WC; Balsara B; Liu Z; Jhanwar SC; Testa JR
Cancer Res; 1996 Oct; 56(19):4297-301. PubMed ID: 8813110
[TBL] [Abstract][Full Text] [Related]
19. Uncovering novel inter- and intrachromosomal chromosome 1 aberrations in follicular lymphomas by using an innovative multicolor banding technique.
Lestou VS; Gascoyne RD; Salski C; Connors JM; Horsman DE
Genes Chromosomes Cancer; 2002 Jun; 34(2):201-10. PubMed ID: 11979554
[TBL] [Abstract][Full Text] [Related]
20. Chromosome alterations associated with in vitro exposure of human fibroblasts to chemical or physical carcinogens.
Popescu NC; Amsbaugh SC; Milo G; DiPaolo JA
Cancer Res; 1986 Sep; 46(9):4720-5. PubMed ID: 3731122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
